CN103787970A - Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method - Google Patents

Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method Download PDF

Info

Publication number
CN103787970A
CN103787970A CN201410014913.9A CN201410014913A CN103787970A CN 103787970 A CN103787970 A CN 103787970A CN 201410014913 A CN201410014913 A CN 201410014913A CN 103787970 A CN103787970 A CN 103787970A
Authority
CN
China
Prior art keywords
difluoro
diketone
reaction
temperature
benzisothiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410014913.9A
Other languages
Chinese (zh)
Inventor
倪歆晨
巫凯
柳青
苟远诚
王涛
黄莉莎
王绪堃
马苏峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Original Assignee
Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Wanquan Dezhong Medical Biological Technology Co Ltd filed Critical Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Priority to CN201410014913.9A priority Critical patent/CN103787970A/en
Publication of CN103787970A publication Critical patent/CN103787970A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/08Aza-anthracenes

Abstract

The invention belongs to the field of medicinal chemistry, and discloses a technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone (I) employing a one-pot method. 6,9-difluoro benzisothiazol-5,10-diketone is an important midbody for pixantrone synthesis, and pixantrone is a new aza-anthraquinone drug, and used for treating multiple recurrent or intractable non-hodgkin lymphoma. The technology is simple in operation, low in cost and beneficial to large-scale synthesis.

Description

The legal system for the treatment of different things alike is for 6,9-difluoro benzisoquinoline-5, the technique of 10-diketone
Technical field
The invention belongs to pharmaceutical chemistry field, be specifically related to a China fir fine jade intermediate 6,9-difluoro benzisoquinoline-5, the synthetic technology of 10-diketone.
Background technology
China fir fine jade is a kind of new naphthazin(e) quinones medicine, is used for the treatment of the Aggressive Non-Hodgkin's of many recurrents or refractory, at present in the clinical study stage three phases.It both can reduce the cardiac toxic that anthracene nucleus medicament is relevant, can not reduce again anticancer therapeutic, was with a wide range of applications.
6,9-difluoro benzisoquinoline-5,10-diketone is a synthetic important intermediate of China fir fine jade, now only has a kind of disclosed synthetic route (CN1282738A, CN1145028, EP0503537A1).Reaction formula is as follows:
Figure 2014100149139100002DEST_PATH_IMAGE002
This technique obtains target product through three-step reaction, and aftertreatment is loaded down with trivial details, and cost is higher, is unfavorable for suitability for industrialized production.
Summary of the invention
In order to overcome the defect existing in technique scheme, the invention discloses one and treat different things alike legal system for 6,9-difluoro benzisoquinoline-5, the technique of 10-diketone, reaction scheme is as follows:
Figure 2014100149139100002DEST_PATH_IMAGE004
Concrete operation step is: 3,4-pyridine dicarboxylic acid joins in oleum, in 45-55 ℃ of stirring 2-3 h, slowly drip difluorobenzene, dropwise rear rising temperature to 80-90 ℃ of reaction 2-4 h, continue to increase the temperature to 135-145 ℃ of reaction 2-4 h and stop heating, be cooled to room temperature, reaction solution is slowly poured in frozen water, in process, temperature control is lower than 25 ℃, regulate pH to 1-2, filter and obtain target product.
The feed ratio (mass ratio) of its Raw is 3,4-pyridine dicarboxylic acid: to difluorobenzene: oleum=1:6.5 ~ 7.0:3.5 ~ 4.2.
?
embodiment:
Following instance is used for illustrating the present invention, is not limited to the present invention, all any modifications of doing within principle of the present invention and spirit, is equal to and replaces and improvement etc., within being all just included in protection scope of the present invention.
?
Example one:
In the reaction vessel of 250 mL, add 20% oleum 40 mL, add 3,4-pyridine dicarboxylic acid 20 g, at 50 ℃, heated and stirred is reacted 2 h, temperature is elevated to 90 ℃, stir and lower slowly drip difluorobenzene 123 mL, heated and stirred is reacted 2.5 h, and normal pressure steams unnecessary to difluorobenzene, increase the temperature to about 140 ℃ reaction 3 h, reaction mixture is cooled to room temperature, slowly pours in 500 mL frozen water, with 40%NaOH adjusting pH to 1, suction filtration, filter cake frozen water drip washing, in THF, recrystallization obtains yellow solid 18.2 g, and yield is 62%.
Mp.:197.0-199.0?℃。
1H?NMR(CDCl 3):9.54(s,1H),9.12(d,1H),8.03(d,1H),7.57(m,2H)
Example two:
In there-necked flask, add 20% oleum 176 mL, add 3,4-pyridine dicarboxylic acid 100 g, at 48 ℃, heated and stirred is reacted 2.5 h, temperature is elevated to 89 ℃, stir and lower slowly drip difluorobenzene 586 mL, heated and stirred is reacted 3 h, and normal pressure steams unnecessary to difluorobenzene, increase the temperature to about 140 ℃ reaction 3.5 h, reaction mixture is cooled to room temperature, slowly pours in 2.5 L frozen water, with 40%NaOH adjusting pH to 2, suction filtration, filter cake frozen water drip washing, in THF, recrystallization obtains yellow solid 82.2g, and yield is 56%.
Mp:197.5-199.9?℃。
Example three:
In the reaction vessel of 3 L, add 20% oleum 633 mL, add 3,4-pyridine dicarboxylic acid 300 g, at 52 ℃, heated and stirred is reacted 2 h, temperature is elevated to 91 ℃, stir and lower slowly drip difluorobenzene 1.9 L, heated and stirred is reacted 3 h, and normal pressure steams unnecessary to difluorobenzene, increase the temperature to about 140 ℃ reaction 4 h, the cooling reaction mixture room temperature that is cooled to, slowly pour in 7.5 L frozen water, with 40%NaOH adjusting pH to 2, suction filtration, filter cake frozen water drip washing, in THF, recrystallization obtains yellow solid 135.5 g, and yield is 52%.
Mp:196.5-198.1?℃。

Claims (2)

1. the legal system for the treatment of different things alike is for 6,9-difluoro benzisoquinoline-5, the technique of 10-diketone (I), it is characterized in that: by 3,4-pyridine dicarboxylic acid joins in oleum, stir 2-3 h in 45-55 ℃, slowly drip difluorobenzene, dropwise rear rising temperature to 80-90 ℃ of reaction 2-4 h, continue to increase the temperature to 135-145 ℃ of reaction 2-4 h and stop heating, reaction solution is cooled to room temperature, slowly pour in frozen water, in process, temperature control, lower than 25 ℃, regulates pH to 1-2, filters and obtains target product
Figure 123510DEST_PATH_IMAGE002
2. method according to claim 2, the feed ratio (mass ratio) of raw material is 3,4-pyridine dicarboxylic acid: to difluorobenzene: oleum=1: 6.5 ~ 7.0: 3.5 ~ 4.2.
CN201410014913.9A 2014-01-14 2014-01-14 Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method Pending CN103787970A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410014913.9A CN103787970A (en) 2014-01-14 2014-01-14 Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410014913.9A CN103787970A (en) 2014-01-14 2014-01-14 Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method

Publications (1)

Publication Number Publication Date
CN103787970A true CN103787970A (en) 2014-05-14

Family

ID=50664080

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410014913.9A Pending CN103787970A (en) 2014-01-14 2014-01-14 Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method

Country Status (1)

Country Link
CN (1) CN103787970A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503537A1 (en) * 1991-03-08 1992-09-16 The University Of Vermont 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones
WO1992015566A1 (en) * 1991-03-08 1992-09-17 Boehringer Mannheim Italia S.P.A. Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents
CN1101046A (en) * 1992-09-08 1995-04-05 佛蒙特大学 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6(2h)-ones
WO1995024407A1 (en) * 1994-03-08 1995-09-14 Boehringer Mannheim Italia, S.P.A. Hetero-annulated indazoles
CN1145028A (en) * 1994-03-28 1997-03-12 泊灵格曼海姆意大利股份公司 A improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt
CN1196055A (en) * 1995-09-13 1998-10-14 意大利柏林格·曼海姆股份公司 2-[[2-(2-hydroxyethyl) amino] ethyl]-5-[[2-methylamino) ethyl] amino] [4,3-gh] isoquinolin-6(2H)-one as antitumor agent
CN101514153A (en) * 2009-04-13 2009-08-26 北京阿格蕾雅科技发展有限公司 Synthesis method for high-purity substituted anthraquinones
CN102731285A (en) * 2012-06-28 2012-10-17 大连理工大学 Anthraquinone compounds and applications thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503537A1 (en) * 1991-03-08 1992-09-16 The University Of Vermont 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones
WO1992015566A1 (en) * 1991-03-08 1992-09-17 Boehringer Mannheim Italia S.P.A. Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents
CN1101046A (en) * 1992-09-08 1995-04-05 佛蒙特大学 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6(2h)-ones
WO1995024407A1 (en) * 1994-03-08 1995-09-14 Boehringer Mannheim Italia, S.P.A. Hetero-annulated indazoles
CN1145028A (en) * 1994-03-28 1997-03-12 泊灵格曼海姆意大利股份公司 A improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt
CN1282738A (en) * 1994-03-28 2001-02-07 诺瓦斯制药公司 Improved method for sgnthesizing 6,9-bis[(2-aminoethyl) amino] benz[g] isoquinoline-5, 10-diketone and its dimaleate
CN1196055A (en) * 1995-09-13 1998-10-14 意大利柏林格·曼海姆股份公司 2-[[2-(2-hydroxyethyl) amino] ethyl]-5-[[2-methylamino) ethyl] amino] [4,3-gh] isoquinolin-6(2H)-one as antitumor agent
CN101514153A (en) * 2009-04-13 2009-08-26 北京阿格蕾雅科技发展有限公司 Synthesis method for high-purity substituted anthraquinones
CN102731285A (en) * 2012-06-28 2012-10-17 大连理工大学 Anthraquinone compounds and applications thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
A. PAUL KRAPCHO,等: "6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,lO-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,lO-diones:Synthesis and Antitumor Evaluations", 《JOURNAL OF MEDICINAL CHEMISTRY》 *
QIJUN HOU,等: "Liquid-phase cascade acylation/dehydration over various zeolite catalysts to synthesize 2-methylanthraquinone through an efficient one-pot strategy", 《JOURNAL OF CATALYSIS》 *
Y.L.N. MURTHY,等: "Synthesis of 2-Methoxy 5-nitro9,10-anthraquinone and study of photophysical properties", 《ORIENTAL JOURNAL OF CHEMISTRY》 *
ZHICHAO ZHANG,等: "An Anthraquinone Scaffold for Putative,Two-Face Bim BH3 α-Helix Mimic", 《JOURNAL OF MEDICINAL CHEMISTRY》 *
朱洪法,等: "《无机化工产品手册》", 31 December 2008, 金盾出版社 *
赵欣: "蒽醌类靶向抗肿瘤化合物的合成与性质研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *
郑卫,等: "具有潜在抗癌活性的米托蒽醌类似物的合成", 《中国抗生素杂志》 *
马燕如: "大黄酚和大黄酸合成实验室工艺研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Similar Documents

Publication Publication Date Title
CN104356092B (en) Preparation method for vortioxetine
CN104530044A (en) Method for synthesizing riociguat
CN103483324B (en) The new preparation process of lapatinibditosylate
CN104370808A (en) Synthesis method of 2,3-dipicolinic acid
CN102304116A (en) Fluorescein compound and preparation method thereof
CN101967120A (en) Preparation method of 2-p-chlorobenzyl pyridine
CN103864960A (en) Preparation method for hydroxypropyl low-melting-point agarose
CN104326975A (en) Preparation method of high-purity milrinone
CN103787924A (en) New purification method of antitumor drug Belinostat
CN103787970A (en) Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method
CN103922925B (en) A kind of production technique of Fenofibric Acid
CN104974057B (en) The preparation method and important intermediate of a kind of bromfenac sodium
CN109096091A (en) The preparation method of cinnamic acid
CN104447303A (en) Preparation technology of carboxybenzaldehyde
CN103896858A (en) Technology for preparing cytosine
CN106008436A (en) Preparation method of alpha crystal form of Iguratimod
CN103102271B (en) Industrialized preparation method of guacetisal and medical application of dry suspension
CN106905135A (en) A kind of preparation method to bromomethyl phenylacetic acid
CN104592249B (en) A kind of preparation method of clopidogrel free alkali
CN104356003B (en) The synthetic method of aromatic series fluoro-containing intermediate m-fluoroaniline
CN102924369A (en) Method for synthesizing 3,5-dibromo-4-iodopyridine by one step
CN109206381B (en) A method for preparing compound intermediate for regulating activity of cannabinoid receptor
CN108863773A (en) The preparation method of 3- methoxy cinnamic acid
CN109384708B (en) Akt inhibitor intermediate SM1 and preparation method thereof
CN102199176A (en) Preparation method for 2-amino-2-deoxy-D-glucose and salt thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140514